Lutetathera

Lutetium-177 DOTATATE · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lutetathera, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET [Phase 3]

See pricing